Genaissance Pharmaceuticals (MM) 뉴스 - GNSC | 주식 나스닥

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

Genaissance Pharmaceuticals, Inc. Invites You to Participate in its First Quarter 2004 Conference Call

Genaissance Pharmaceuticals, Inc. Invites You to Participate in its First Quarter 2004 Conference Call NEW HAVEN, Conn., May 4...

Genaissance Pharmaceuticals Signs Amendment to License Agreement for Patents on Genes Associated With Sudden Cardiac Death Syndr

Genaissance Pharmaceuticals Signs Amendment to License Agreement for Patents on Genes Associated With Sudden Cardiac Death Syndromes Simplifies...

Genaissance Pharmaceuticals Signs Agreements to Support its Development of Tests for Sudden Cardiac Death Syndromes

Genaissance Pharmaceuticals Signs Agreements to Support its Development of Tests for Sudden Cardiac Death Syndromes - Intellectual Property and...

Genaissance Pharmaceuticals and Lark Technologies Receive Shareholder Approval For and Close Merger

Genaissance Pharmaceuticals and Lark Technologies Receive Shareholder Approval For and Close Merger - Combined Entity Expands Genaissance's...

SEC Declares Genaissance's Registration Statement Effective

SEC Declares Genaissance's Registration Statement Effective Stockholder Vote on Merger with Lark Technologies Set for April 1 NEW HAVEN, Conn...

Genaissance Pharmaceuticals Reports Fourth Quarter And Full Year Results for 2003

Genaissance Pharmaceuticals Reports Fourth Quarter And Full Year Results for 2003 - Highest Fourth Quarter and Full Year Revenues in Company's...

SEQUENOM Systems Used to Determine Origin of Mad Cow Case

SEQUENOM Systems Used to Determine Origin of Mad Cow Case Independent Analyses Conducted by Two Genetic Testing Companies for the USDA SAN DIEGO...

Genaissance Pharmaceuticals Analyzed Samples for United States Department of Agriculture in Mad Cow Disease Investigation

Genaissance Pharmaceuticals Analyzed Samples for United States Department of Agriculture in Mad Cow Disease Investigation - Opportunity for Entry...

Genaissance Pharmaceuticals, Inc. to Acquire Lark Technologies, Inc.

Genaissance Pharmaceuticals, Inc. to Acquire Lark Technologies, Inc. - Acquisition Complements Genaissance's Pharmacogenomic Base Business - NEW...

Genaissance Pharmaceuticals Enters Into HAP(TM) Technology License Agreement With Novo Nordisk

Genaissance Pharmaceuticals Enters Into HAP(TM) Technology License Agreement With Novo Nordisk NEW HAVEN, Conn., Dec. 18 /PRNewswire-FirstCall/...

Genaissance Pharmaceuticals and Ferring Pharmaceuticals Sign Pharmacogenomics Agreement

Genaissance Pharmaceuticals and Ferring Pharmaceuticals Sign Pharmacogenomics Agreement NEW HAVEN, Conn., Dec. 11 /PRNewswire-FirstCall/...

Genaissance Pharmaceuticals and INTEC Web and Genome Informatics Corporation Announce Commercialization Progress in Japan

Genaissance Pharmaceuticals and INTEC Web and Genome Informatics Corporation Announce Commercialization Progress in Japan NEW HAVEN, Conn., and...

Thanks. I don't own any. Just curious about the company. I've been waiting for them to take the next step to legitimize their science but it hasn't been forthcoming. Still waiting.

FYI - a prospectus came out that shows deteriorating financials. So be careful! Good luck.

http://www.shareholder.com/GNSC/EdgarDetail.cfm?CompanyID=GNSC&CIK=1110009&FID=1047469-05-15...

👍️0

gator16 20 년 전

I own a lot of GNSC..maybe too much..I keep hearing great things are coming though....guess I will have to wait a while !
98000 shrs at $3.26 groan !!

👍️0

DougS. 20 년 전

Anyone out there follow this company besides me???

👍️0

gator16 20 년 전

Welcome everyone to this new board. This company is the future !!

👍️0

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Genaissance Pharmaceuticals (MM) (GNSC)

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

GNSC 뉴스

Genaissance Pharmaceuticals, Inc. Invites You to Participate in its First Quarter 2004 Conference Call

Genaissance Pharmaceuticals Signs Amendment to License Agreement for Patents on Genes Associated With Sudden Cardiac Death Syndr

Genaissance Pharmaceuticals Signs Agreements to Support its Development of Tests for Sudden Cardiac Death Syndromes

Genaissance Pharmaceuticals and Lark Technologies Receive Shareholder Approval For and Close Merger

SEC Declares Genaissance's Registration Statement Effective

Genaissance Pharmaceuticals Reports Fourth Quarter And Full Year Results for 2003

SEQUENOM Systems Used to Determine Origin of Mad Cow Case

Genaissance Pharmaceuticals Analyzed Samples for United States Department of Agriculture in Mad Cow Disease Investigation

Genaissance Pharmaceuticals, Inc. to Acquire Lark Technologies, Inc.

Genaissance Pharmaceuticals Enters Into HAP(TM) Technology License Agreement With Novo Nordisk

Genaissance Pharmaceuticals and Ferring Pharmaceuticals Sign Pharmacogenomics Agreement

Genaissance Pharmaceuticals and INTEC Web and Genome Informatics Corporation Announce Commercialization Progress in Japan

Genaissance Pharmaceuticals Expands Into Consumer Market with a HAP(TM) Technology License Agreement with Sciona Limited

Genaissance Pharmaceuticals Reports Third Quarter Results

Genaissance Pharmaceuticals Describes Link Between Genetic Markers and Drug Response in Cardiovascular Disease

GNSC Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Genaissance Pharmaceuticals (MM) (GNSC) 뉴스

Genaissance Pharmaceuticals (MM) (GNSC)

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

GNSC 뉴스

Genaissance Pharmaceuticals, Inc. Invites You to Participate in its First Quarter 2004 Conference Call

Genaissance Pharmaceuticals Signs Amendment to License Agreement for Patents on Genes Associated With Sudden Cardiac Death Syndr

Genaissance Pharmaceuticals Signs Agreements to Support its Development of Tests for Sudden Cardiac Death Syndromes

Genaissance Pharmaceuticals and Lark Technologies Receive Shareholder Approval For and Close Merger

SEC Declares Genaissance's Registration Statement Effective

Genaissance Pharmaceuticals Reports Fourth Quarter And Full Year Results for 2003

SEQUENOM Systems Used to Determine Origin of Mad Cow Case

Genaissance Pharmaceuticals Analyzed Samples for United States Department of Agriculture in Mad Cow Disease Investigation

Genaissance Pharmaceuticals, Inc. to Acquire Lark Technologies, Inc.

Genaissance Pharmaceuticals Enters Into HAP(TM) Technology License Agreement With Novo Nordisk

Genaissance Pharmaceuticals and Ferring Pharmaceuticals Sign Pharmacogenomics Agreement

Genaissance Pharmaceuticals and INTEC Web and Genome Informatics Corporation Announce Commercialization Progress in Japan

Genaissance Pharmaceuticals Expands Into Consumer Market with a HAP(TM) Technology License Agreement with Sciona Limited

Genaissance Pharmaceuticals Reports Third Quarter Results

Genaissance Pharmaceuticals Describes Link Between Genetic Markers and Drug Response in Cardiovascular Disease

GNSC Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

광고 제거